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Abstract
Background: With increasing access to effective Anti-Retroviral Therapy (ART), the proportion of children who
survive into later childhood with HIV has increased. Consequently, caregivers are constantly being confronted with
the dilemma of ‘if’, ‘when’, and ‘how’ to tell their children living with HIV their status. We aimed to determine the
prevalence and predictors of disclosure and explore the barriers caregivers face in disclosing HIV status to children
living with HIV in Gombe, northeast Nigeria.
Methods: We conducted a sequential, explanatory, mixed-methods study at the specialist Paediatric HIV clinic of
the Federal Teaching Hospital Gombe, northeast Nigeria. The quantitative component was a cross sectional,
questionnaire-based study that consecutively recruited 120 eligible primary caregivers of children (6–17 years) living
with HIV. The qualitative component adopted an in-depth one-on-one interview approach with 17 primary
caregivers. Primary caregivers were purposively selected to include views of those who had made disclosure and
those who have not done so to gain an enhanced understanding of the quantitative findings. We examined the
predictors of HIV status disclosure to infected children using binary logistic regression. The qualitative data was
analysed using a combined deductive and inductive thematic analysis approach.
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Results: The mean age of the index child living with HIV was 12.2 ± 3.2 years. The prevalence of disclosure to
children living with HIV was 35.8%. Children living with HIV were 10 times more likely to have been told their status
if their caregivers believed that disclosure had benefits [AOR = 9.9 (95% CI = 3.2–15.1)], while HIV-negative compared
to HIV-positive caregivers were twice more likely to make disclosures [AOR = 1.8 (95%CI = 0.7–4.9)]. Girls were 1.45
times more likely than boys to have been disclosed their HIV positive status even after adjusting for other variables
[AOR = 1.45 (95% CI = 0.6–3.5)].
Caregivers expressed deep-seated feeling of guilt and self-blame, HIV-related stigma, cultural sensitivity around HIV,
and fears that the child might not cope as barriers to non-disclosure. These feeling were more prominent among
HIV-positive caregivers.
Conclusion: The process of disclosure is a complex one and caregivers of HIV positive children should be
supported emotionally and psychologically to facilitate disclosure of HIV status to their children. This study further
emphasises the need to address HIV-related stigma in resource constrained settings.
Keywords: HIV, Disclosure, Barriers, Sequential, Explanatory mix-methods
Background
The number of new HIV infections among children has
decreased globally due to effective preventive strategies
such as the prevention of mother to child transmission
(PMTCT) of HIV [1]. Nevertheless, Nigeria still has the
second largest HIV epidemic globally and contributes al-
most a third of paediatric HIV infections worldwide [2].
By 2017, with 380,000 children living with HIV infection,
Nigeria had the largest burden globally, with a quarter of
this number being on ART [3].
With increasing access to effective ART which has re-
duced HIV-related deaths by 42% since the year 2000,
the proportion of children who survive into later child-
hood and live chronically with HIV has increased [4].
Consequently, caregivers of children living with HIV are
constantly being confronted with the dilemma of ‘if’,
‘when’, and ‘how’ to tell these infected children of their
HIV status [5, 6]. Disclosure of HIV to infected children
poses serious implications for the child and their care-
givers that relate to treatment adherence, adjusting to
the illness at different stages of life such as entering ado-
lescence and relationship with the wider community [7].
Disclosure of HIV to infected children is a critical
component of the process of living with HIV and is con-
sidered pivotal to the continuum of care [6, 8]. Disclos-
ure is considered to have been done when a child has
been fully informed of his or her HIV status and if the
terms HIV, AIDS, or any local term specifically associ-
ated with HIV/AIDS had been used in a discussion with
the child about their health [6]. Rates of disclosure in
children in sub-Saharan Africa vary widely, ranging from
0 to 69.2%, [9] despite the World Health Organization
(WHO) recommending in 2011 that children from 6 to
12 years living with HIV should be gradually informed
about their status in an ongoing, age-appropriate man-
ner [6]. This may be related, but not limited to a com-
plex social and cultural barrier regarding how child-
caregiver relationships are conceptualised in the context
of healthcare, with children expected to be compliant re-
cipients of services, while the caregiver interacts with the
health system on their behalf [5].
There is evidence to suggest that it is beneficial to dis-
close HIV status to infected children before they reach
adolescent as it fosters ART adherence, participation in
ongoing care, and psychological resilience, while lessen-
ing the risk of horizontal transmission due to risky sex-
ual behaviour [9, 10]. Most research on disclosure of
HIV to infected children has mainly been quantitative
focusing on the determinants of disclosure, patterns of
disclosure, the differences between non-disclosers and
disclosers, and the impact of disclosure on certain HIV
outcomes in children and adolescents [9]. It is, however,
difficult to have an enhanced understanding of the ‘why’,
and the ‘how’ behind the evidence in terms of why dis-
closure is done or not done, and how disclosure is con-
ceptualized by caregivers and their children living with
HIV [6, 9]. Gaining an enhanced understanding of the
contextual and granular issues behind the ‘numbers’
would be pivotal in planning, implementing and evaluat-
ing strategies to scale up childhood disclosure and aiding
improved childhood age-appropriate engagement in
HIV/AIDS care.
Mixed method approach; a combination of quantita-
tive and qualitative research paradigms produces an en-
hanced understanding and granular evidence in
comparison to ‘mono-methods’ research [11, 12]. There
are limited African studies that have used mixed meth-
odologies to explore the complex and context-specific
issue of disclosing HIV to children living with HIV [5,
13, 14]. Combining research methods draws on the com-
monalities of both paradigms and harnesses their differ-
ences in a complementary manner to generate robust
research evidence, which may contribute to the under-
standing of a complex phenomenon like disclosure [12].
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This research, therefore, was designed with the foregoing
in mind, drawing on the strengths of both paradigms to
gain enhanced understanding of HIV disclosure to chil-
dren living with HIV. Our aim was to determine the
prevalence and predictors of disclosure and explore the
barriers caregivers face in disclosing HIV status to in-
fected children in Gombe, northeast Nigeria.
Methods
Study setting and population
The study was conducted at the Federal Teaching Hos-
pital, Gombe, a 450-bed capacity tertiary health facility
located in Gombe State, northeast Nigeria. Gombe State
is strategically located at the centre of the northeast sub-
region of Nigeria between latitudes 90°30’ and 12°30’N
and longitudes 8°5’ and 11°45’ E and has a population of
2.4 million people, with children 18 years and below be-
ing approximately 50% of the population and has a pro-
jected population growth rate of 2.3% per year [15]. The
HIV sero-prevalence of 3.4% in Gombe State is identical
to the National sero-prevalence rate [16].
Established in the year 2000, the Federal Teaching
Hospital Gombe serves as the major referral centre for
hospitals within the state and from neighbouring states
of the northeast region of Nigeria, which has a combined
population of 23,558,674 [15]. The facility has a specia-
lised paediatric HIV/AIDS clinic operational since the
inception of the hospital and serves about 200 children
from birth till they turn 18 years. Services offered include
PMTCT, HIV counselling and testing (HCT), monitor-
ing/follow-up of patients including viral load; treatment
of opportunistic and other infections and provision of
ART. Clinics are held once a week and about 30 children
usually accompanied by their primary caregivers are
consulted during clinic days. The clinic is run by a con-
sultant paediatrician (EI) specialised in HIV/AIDS care,
supported by four paediatric trainees, five specialist
nurses, laboratory and pharmacy staff on clinic days.
Study design
This was a sequential, explanatory, mixed-methods study
(Fig. 1) that used a combined quantitative and qualitative
research design in two distinct phases. The initial phase
(phase 1) was a quantitative design, was cross-sectional
descriptive in nature and was questionnaire based. In
the next phase (phase 2) which was conducted to further
explain and enhance our quantitative findings, we
adopted a qualitative design that involved in-depth inter-
views of primary caregivers of HIV-positive children.
Participants
All primary caregiver responsible for the care of children
aged 6–17 years living with HIV and attending the spe-
cialist paediatric HIV clinic of the Federal Teaching
Hospital Gombe, Nigeria, who consented to the study
were eligible for inclusion in the study. We defined a
primary caregiver as an adult aged ≥18 years attending
our specialist clinic with their HIV-positive child, and
responsible for the day-to-day care of the child (6–17
years), including but not limited to biological parents.
We chose caregivers of children of aged 6–17 years
[those with the cognitive skills and emotional maturity
of a normally developing child of 6–17 years] because
the WHO recommends that children of this age group
should have disclosure of their HIV status made to them
in an age-appropriate manner [6]. HIV positive children
who did not have an identified primary caregiver were
excluded from the study. One hundred and twenty-five
(125) out of the 200 primary caregivers attending the
specialist clinic with their HIV-positive children gave
their consent and were recruited into the study. Partici-
pants were advised that they could withdraw from the
study at any point.
Data collection
All data for this study was collected between October
2017 and September 2018.
Fig. 1 A visual representation of the sequential, explanatory, mixed-methods design adopted in this study
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Phase 1: quantitative component
A pre-tested questionnaire (Additional file 1), developed
specifically for the purposes of this study was adminis-
tered to primary caregivers of HIV-positive children in
the absence of the child. The questionnaire was devel-
oped based on our understanding of the study popula-
tion and after reviewing the literature on predictors of
disclosure of HIV status to infected children in the set-
ting of sub-Saharan Africa. The questionnaire captured
information on caregivers’ sociodemographic character-
istics, their relationship with the index child, disclosure
status of the index child, opinion about the process of
HIV disclosure and information about the care and
management of the HIV-positive child. Disclosure was
considered to have been done when a child had been
fully informed of his or her status and if the terms HIV,
AIDS, or any local term specifically associated with
HIV/AIDS had been used in a discussion with the child
about their health [6]. The quantitative data was ana-
lysed after phase 1 and the findings informed the next
sequential phase which was conducted to give an in-
depth understanding and explanations for disclosure and
non-disclosure among primary caregivers (Fig. 1).
Phase 2: qualitative component
In-depth one-on-one qualitative interviews were conducted
with 17 primary caregivers who were selected purposively
from the 125 primary caregivers who met the eligibility
criteria. Caregivers who were interviewed were selected spe-
cifically based on whether or not they had disclosed to the
child his/her HIV status. (Table 1). We aimed to maximize
diversity with respect to caregivers’ HIV status, thus, we in-
cluded HIV positive and HIV negative caregivers to provide
multiple perspectives and lived experiences. Using this ap-
proach, we sought to gain an in-depth understanding
through the lived experiences of caregivers, the reasons why
most caregivers in our setting were reluctant to make dis-
closure to their children living with HIV.
Interviews were held at times and locations determined
by participants to be convenient for them. Interviews were
semi-structured, used topic guides (Additional file 2) and
were conducted by co-authors (AA, MPR and AI) who
had previous experience of conducting qualitative inter-
views and facilitating focus group discussions. One inter-
view each was conducted per primary caregiver and lasted
about 60–90min. Interviews were conducted in either
Hausa (the predominant language spoken in northern
Nigeria) or English language based on which language the
participants preferred. Interviews conducted in Hausa,
were professionally transcribed verbatim into Hausa lan-
guage, before being translated to English. Narrative data
were then cross-checked for trustworthiness by a co-
author (co-author AA) who could read, write, and com-
municate fluently in Hausa by listening to the audio re-
cording of interviews in Hausa repeatedly while reading
through transcribed text in English.
Table 1 Characteristics of the 17 caregivers interviewed in the qualitative component of the study
Caregiver code no Type of caregiver Caregiver HIV status Child’s age category* Orphan? Disclosure done?
01 Uncle Negative Mid adolescence Yes Yes
02 Mother Positive Mid adolescence No Yes
03 Mother Positive Early adolescence No No
04 Adopted mother Negative Early adolescence Yes No
05 Mother Positive Early adolescence Yes Yes
06 Mother Positive Early adolescence No No
07 Mother Positive School age No No
08 Aunt Negative Early adolescence Yes Yes
09 Mother Positive School age No No
10 Aunt Negative Early adolescence Yes Yes
11 Mother Positive School age No No
12 Father Positive Mid adolescence No Yes
13 Father Positive Late adolescence No Yes
14 Mother Positive School age No No
15 Father Positive Mid adolescence No Yes
16 Father Positive Early adolescence No No
17 Father Positive Early adolescence No No
Note: Caregivers’ gender, parent vs non parent caregiver, HIV positive/ negative status, varying levels of education and religious backgrounds were other
characteristics that were considered in purposively selecting caregivers for the in-depth interviews in addition to the main characteristics of whether or not
caregivers have made disclosure to their children. *School age (6–9 years), Early adolescence (10–13 years), Mid adolescence (14–16 years) and Late adolescence
(17–18 years) [17].
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Data analysis
All quantitative data generated were processed and ana-
lysed using the IBM Corp SPSS statistics for windows
version 24.0 (Armonk, NY: IBM Corp). Proportions, and
percentages were reported for categorical variables, while
mean and standard deviations were reported for con-
tinuous variables which were normally distributed.
To determine which caregiver or child’s characteristic
(the independent variables) that was predictive of disclos-
ure of HIV status to infected children (the dependent vari-
able), multiple logistic regression models were fitted for
variables that were significantly associated with disclosure
from the univariate analysis. The regression models were
adjusted for confounders including age of the index child,
duration the index child has been diagnosed HIV-positive
and how long the index child has been on ART. The ad-
justed odds ratio (AOR), and 95% CI are reported, with
significance level set at p-values of < 0.05.
Qualitative narrative data generated from transcripts
of in-depth interviews were imported into the QSR
NVivo software version 10 (QSR International Pty Ltd.
Version 10, 2012) and analysed thematically using the
approach described by Braun and Clark [18]. The the-
matic analysis was based on a combined inductive and
deductive approach [12]. The inductive approach deter-
mined meanings that emerged from within the data,
while the deductive approach looked for categories and
meaning within the data that were determined a priori
based on evidence from literature. Researchers (OW and
AA) separately read the transcripts several times to
familiarize themselves with the key ideas, paying atten-
tion to recurring themes or patterns. Initial themes and
their sub–themes were noted as codes. Transcripts were
again re–read, re–checking for themes, how new themes
supported the data and vice versa, identifying relation-
ships within and between themes. This process was
followed in an iterative manner until thematic saturation
was reached. The emergent themes and sub-themes
were then discussed and agreed on collectively by co-
authors, and where there was a disagreement on a theme
or sub-theme, a third person (a co-author) was con-
sulted to help resolve the disagreement.
Results
Quantitative findings
Primary caregivers characteristics and opinion on disclosure
to HIV-infected children
A total of 125 caregivers were recruited to this study. Of
these, data was incomplete or missing for 5 participants
leaving 120 participants that were included in the final
analysis. There were 98 (81.7%) female caregivers, giving
a female to male caregiver ratio of 4.5:1. The mean age
of primary caregivers included in the study was 39.2 ± 9
years. Majority [77.5% (93/120)] of caregivers were the
biological parents of the HIV positive child. Forty seven
percent of caregivers were educated up to the tertiary
level. Majority, 77.5% (93/120) of caregivers believed that
disclosure had benefits and should be made to children
living with HIV (Table 2).
Characteristics of index children living with HIV
The mean age of index children living with HIV was
12.2 ± 3.2 years and there was no statistically significant
difference between the ages of boys and girls with p =
0.363 (Table 3). There were 60 (50%) Boys, making a Boys
to Girls ratio of 1:1. The mean age at first diagnosis of
HIV in these children was 4.9 ± 3.7 years, while the mean
duration of treatment with ART was 7.0 ± 3.9 years, with
no significant differences in boys and girls (Table 3). Most,
98.3% (118/120) of children were on ART.
Prevalence of disclosure of HIV status to infected children
The prevalence of HIV status disclosure to infected chil-
dren was 35.8% (43/120). More mothers, 34.9% (15/43)
compared to fathers, 11.6% (5/43) had made disclosures,
however, the differences were not statistically significant
(p = 0.212). Disclosure rate was higher in girls compared
to boys, 41.7% vs 30%, p = 0.253 (Table 3).
Predictors of disclosure of HIV status to infected children
HIV-positive children were ten times more likely to have
been told their status if their caregivers believed that dis-
closure was beneficial and should be made to children liv-
ing with HIV [AOR= 9.9 (95% CI = 3.2–15.1)]. Children’s
gender, caregiver’s religion, and whether the caregiver was
the child’s biological parent or not did not predict disclos-
ure (Fig. 2). Male caregivers compared to females were 3
times more likely, while HIV-negative caregivers com-
pared to HIV-positive caregiver were 2 times more likely
to have made disclosure to their children, however, the
odds were not statistically significant (Fig. 2). Girls were
1.45 times more likely than boys to have been disclosed
their HIV positive status even after adjusting for other var-
iables [AOR = 1.45 (95% CI = 0.6–3.5)].
Qualitative findings
Three main themes; a) barriers to disclosure; b) the
process of disclosure; and c) the perceived impact of dis-
closure on the child arose from the qualitative data re-
lated to why most caregivers have not made disclosure
to their children living with HIV. The emergent sub-
themes within the three themes (Table 4) are presented
below and supported with verbatim quotes.
Barriers
Stigma and discrimination
There was consensus among parents, in a recurring
manner across the interviews that discrimination and
Wariri et al. BMC Public Health          (2020) 20:373 Page 5 of 13
stigma were major deterrents to disclosure of HIV to
their infected children. They opined that stigmatization
in the community was still quite high and expressed
deep-seated fears of what appeared to be the commu-
nity’s way of labelling and ostracizing HIV positive indi-
viduals. The discussion highlighted their fears of the
negative impact of stigma and discrimination on their
wards and they were reluctant to expose their children
to such; fearing the impact it could have on them, hence
they would rather resort to non-disclosure.
“…honestly when he tells someone, almost the en-
tire area [community] will come to know he is posi-
tive and knowing his status, they will start
discriminating against him and when he goes some-
where, he may not be welcomed…at the time they
start discriminating him he will feel hated and will
prefer to die” (Caregiver 1: HIV negative caregiver
of HIV orphan)
“…when other children hear about it [the child’s
HIV status], they will start to disassociate them-
selves from him. These are my reasons why a child
should not be disclosed his HIV status” (Caregiver
6: HIV positive caregiver of adolescence living with
HIV)
Blame, guilt, and responsibility
The caregivers shared the view that while already having
to deal with the pain of watching their children grow-up
HIV positive, disclosure was made more complex by
thoughts of questions that would arise during the
process. The caregivers in a repetitive manner harboured
strong feelings of guilt and self–recrimination; antici-
pated being blamed and despised by their children for
what they unwittingly brought upon them, and some
considered the possibility of loss of the respect they have
from their children, hence preferring non-disclosure.
These views were more prominently expressed by HIV
positive caregivers.
"This [disclosure] can lead him to query his parents
from where and how they came about the disease…
He may think his parents are irresponsible and it
led to them contracting HIV, so you see the parent
will not want to tell him because they fear they may
lose the respect he has for them. So, this makes dis-
closure problematic for the parents. (Caregiver 2:
HIV positive caregiver of adolescent living with
HIV)
“I don’t know what my child will think of me if he
hears I gave him HIV. He may say I have harmed
Table 2 Characteristics of 120 caregivers of children living HIV with included in quantitative component of the study
Variable Characteristics Frequency (n) Percentage (%)
Gender Male 98 81.7
Female 22 18.3




Relationship with Child Biological parent 93 77.5
¶Other family member 27 22.5
Caregiver’s HIV status Positive 94 78.3
Negative 26 21.7
Opinion about telling a child his/her HIV status Agree to disclose 93 77.5
Disagree to disclose 27 22.5
Opinion on benefits of telling a child his/her HIV status No benefits 17 14.2
There are benefits 103 85.8
Opinion about appropriate age of disclosure School age 5 4.2
Early adolescence 31 25.8
Mid adolescence 53 44.2
Late Adolescence 31 25.8
Values presented as mean (SD), unless otherwise indicated, n (%) = Frequency (percentage)
School age (6–9 years), Early adolescence (10–13 years), Middle adolescence (14–16 years), Late adolescence (17–18 years) as described by Cromber et al. [17]
¶Others: Sister, Brother, Neighbour, Step-mother, Guardian, and unknown person
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him because it is like harming him by infecting him
with the virus.” (Caregiver 7: HIV positive caregiver
of a school age child living with HIV)
The main reason parents will keep it a secret, like I
told you, is the fear of what the children will think
of them and how they look at them once they dis-
cover that their parents have the disease [HIV]…
they will begin to ask themselves how their father
became infected… is it through sex? (Caregiver 17:
HIV positive caregiver of an adolescent living with
HIV).
Fear of the unknown
Many caregivers feared that their children could not
handle the news and their situation could be worsened
following disclosure of their HIV positive status. Their
uncertainty about the impact of this news on children
who had grown up seemingly unaware of any problems
could be felt across the discussions repeatedly. They
expressed fears about this knowledge resulting in de-
pression, anxiety, hopelessness and even suicidal
thoughts in their wards.
“…he may resolve to take something [poison] to end
his life because he will believe when told that he is
HIV positive that his life is of no importance or that
his parents have cheated him by bringing him into
the world with this illness” (Caregiver 5: HIV posi-
tive caregiver of adolescent living with HIV)
“I keep wondering what her state of mind will be
when I finally confide in her” (Caregiver 14: HIV
positive caregiver of a school age child living with
HIV)
The ‘right time’
During discussions, it became apparent that 14–15 years
and above was deemed to be the ‘right time’ to begin
disclosure, thus, having younger children acted as a
Table 3 Characteristics of index children living with HIV (N = 120) included in the quantitative component of the study
Variable Boys (N = 60) Girls (N = 60) p value Total (N = 120)
Age (years) 11.9 (2.9) 12.5 (3.5) 0.363* 12.2 (3.2)
Age at 1st diagnosis (years) 5.1 (3.8) 4.6 (3.5) 0.435* 4.9 (3.7)
Duration of ART treatment (years) 6.6 (3.4) 7.6 (4.2) 0.98* 7.0 (3.9)
Overall Age group: n (%)
School age 11 (18.8) 11 (18.3) 22 (18.3)
Early adolescence 25 (41.7) 33 (55.0) 58 (48.3)
Mid adolescence 15 (25.0) 11 (18.3) 26 (21.7)
Late adolescence 9 (15.0) 5 (8.3) 0.472** 14 (11.7)
School Attendance: n (%) 60 (100) 58 (96.7) 0.476** 118 (98.3)
On Antiretrovirals: n (%) 59 (98.3) 58 (96.7) 0.559** 117 (97.5)
Prevalence of disclosure: n (%) 18 (30.0) 25 (41.7) 0.253** 43 (35.8)
∫Disclosure rate by age-group: n (%)
School age 1 (9.1) 2 (18.2) 3 (13.6)
Early adolescence 3 (12.0) 10 (30.3) 13 (22.4)
Mid adolescence 6 (40.0) 8 (72.7) 14 (53.8)
Late adolescence 8 (88.9) 5 (100) 0.001** 13 (92.9)
Who made disclosure: N = 43 n (%)
Mother alone 7 (38.9) 8 (32.0) 15 (34.9)
Father alone 0 (0.0) 5 (20.0) 5 (11.6)
Health worker 4 (22.2) 9 (36.0) 13 (30.2)
Grandmother 2 (11.1) 1 (4.0) 3 (7.0)
¶Others 5 (27.8) 2 (8.0) 0.212** 7 (16.3)
Values presented as mean (SD), unless otherwise indicated, n (%) = Frequency (percentage), *Independent t-test p-values reported, **Chi-square
p-values reported
∫Disclosure rate by age-group calculated based on overall number of children within each age group category (disclosed and non-disclosed)
¶Others: mother and father combined, Sister, Brother, Neighbour, Step-mother, Guardian, and unknown person
School age (6–9 years), Early adolescence (10–13 years), Middle adolescence (14–16 years), Late adolescence (17–18 years) as described by Cromber et al. [17]
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barrier to disclosure. Most caregivers perceived that at
that age, the child would have attained the ability to
process such information. Other caregivers’ opinion was
that since girls began to mature earlier than boys, the
process should begin earlier in them.
“The child doesn’t have a right to know his or her
status till age 15years. It is when they reach 15 years
that the time is right for them to know their status
and condition, they are in…” (Caregiver 11: HIV
positive caregiver of a school age child living with
HIV)
“…in primary school between 7,8,9 to 10 years it
may be difficult- for instance for female you can tell
her from 10 years at least she has grown up…How-
ever, a male child can wait until when he is like 14,
15 years…” (Caregiver 1: HIV negative caregiver of
an HIV orphan)
Multi-layer disclosure of secrets
In a repeated manner, the caregivers emphasized the se-
crecy surrounding being HIV positive or having an HIV
positive family member in their local context. Anxiety
about knowledge of the child’s and possibly parent status
subsequently becoming known to the larger community
through the child following disclosure was palpable. This
concern appeared to be a primary contributor to most
parents suggesting an optimal disclosure age purely
based on when the child would be able to keep his/her
“mouth shut”.
“…they will begin to say it outside and the neigh-
bours may ask you in order to clarify the informa-
tion, and it is from there that others will get to
Fig. 2 Comparative odds ratios for likelihood of telling a child his/her HIV status by caregiver and child’s characteristics. Note: all variables were
adjusted for child’s age, duration (in years) the child has been on HAART, and duration (in years) since the child was first diagnosed with HIV
Table 4 Major emergent themes and sub-themes from the
qualitative data
Themes Sub-Themes
Barriers Stigma and discrimination
Blame, guilt and responsibility
Fear of the unknown
The ‘right time’
Multi-layer disclosure of secrets
Cultural sensitivity
Process Ongoing and gradual
Other peoples’ or shared responsibilities
Impact Mutually empowering
Intimacy and peer support
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know the family’s secret” (Caregiver 7: HIV positive
caregiver of a school age child living with HIV)
‘The children should be told that they can only tell
a select few people who are also positive and who
can keep this information secret, so that they will
know that it is not everywhere you go talking about
your status". (Caregiver 16: HIV positive caregiver
of a school age child living with HIV)
Cultural sensitivity
There was a recurring theme during the discussions on
the impact of cultural practices or beliefs on the disclos-
ure process especially on issues relating to HIV and
sexuality. Caregivers agreed there was a tendency to shy
away from discussing topics relating to sex with their
wards and admitted this presented a huge barrier to
disclosure.
“Assuming it is in our culture to always give an-
swers to whatever [including sexual topics] a child
asks by telling them the truth; I don’t think there
will be problems in disclosing HIV to our children”




The caregivers mostly agreed that disclosure needed to
be done gradually, as a stepwise and ongoing process.
They agreed that a process of gradually breaking the
news over a long period would help the child cope
better.
“For a difficult issue like HIV, disclosure has to be
gradual, systematic and continuous…it has to be
slow, phase by phase” (Caregiver 17: HIV positive
caregiver of an adolescent living with HIV).
Other peoples’ or shared responsibilities
Most of the caregivers considered the process of disclos-
ure as ‘other peoples’ or a ‘shared’ responsibility, believ-
ing that health care workers should play a key role in
the process; either as facilitators or to provide support
while caregivers make disclosure. Some, especially the
HIV positive female caregivers emphasized parental re-
sponsibility to make disclosure or pointed fingers at fa-
thers as responsible, blaming them for infecting the rest
of the family.
“The responsibility lies on both the parents and the
doctors. The parents are the ones that know the
problem of their children…On the other hand, the
doctors can disclose to him because they are the
ones that see him and prescribe medicine for him,
they tell him the steps to take to protect his
health…” (Caregiver 11: HIV positive caregiver of a
school age child old living with HIV)
“The father has the responsibility of disclosing the
child’s HIV status to him since he is the person that
brought the disease home/ into the family” (Care-




Full disclosure was repeatedly described as associated
with feelings of relief for the caregivers and liberating for
the child throughout the discussions. Involvement of
children in HIV management following disclosure was a
major positive effect observed by caregivers who had
made disclosure.
“I saw clearly that if I left him to grow much older
before telling him, he is likely to say I have been un-
fair to him by keeping him in darkness/ hiding
things from him. We both have peace of mind since
he came to understand the illness” (Caregiver 8:
HIV negative caregiver of an adolescent HIV
orphan)
“When the doctor disclosed it to him, I saw some
changes in his behaviour and noticed he was more
serious about committing himself to taking his
drugs more than before” (Caregiver 13: HIV posi-
tive caregiver of an adolescent living with HIV)
Intimacy and peer support
Caregivers described how full disclosure positively im-
pacted on their child or ward as it brought intimacy and
an opportunity to get support from family members and
peers in school who were dealing with similar situations
or had someone who was also HIV positive. This intim-
acy or support was not possible prior, as the child’s con-
dition was kept secret.
“He later told me that in school he has a friend
whom he confided in about his HIV status and who
also told him about his sister at home who had
HIV. You see that person also knows about the dis-
ease from personal experience, so he won’t go about
telling people that my son is infected …and he can
now support my son” (Caregiver 2: HIV positive
caregiver of an adolescent living with HIV)
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Discussion
The strength of our study was that it combined quanti-
tative and qualitative methodologies in a sequential and
complementing manner to gain in-depth information on
the predictors, and experience of caregivers on the dis-
closure of HIV status to infected children attending an
HIV-specialist clinic in the northeast of Nigeria. Thirty-
six percent of the HIV positive children in this study
have had their HIV status formally disclosed to them by
their caregivers. This figure is much higher than an earl-
ier report by Brown et al. (13.5%) in Ibadan, South-West
Nigeria, and may be attributed to differences in study
population, context, and increasing awareness about
HIV disclosure [19]. For example, most children studied
in the earlier report were pre-adolescent (mean age
8.8 ± 2.2 years) compared to our study in which the ma-
jority were in early and mid-adolescence (mean age
12.2 ± 3.2 years), making disclosure more likely in our
study with corresponding higher prevalence. More re-
cent studies in Nigeria by Ubesie et al., [20] and Odiachi
et al. [21] reported prevalence of disclosure to HIV posi-
tive children of 29.5 and 30.9% respectively; comparable
to our findings which suggests an increase prevalence of
disclosure to Nigerian children living with HIV within
recent time. Although relatively higher than most re-
ports from within Nigeria and the African continent, [5,
22–28] our disclosure rate are lower compared with
findings from the US, Canada and Europe [29–31].
Majority of caregivers appeared to support the idea of
disclosing HIV to positive children as necessary how-
ever, up to 70% of them considered that it should be left
till mid adolescence when the child would have become
“mature”. There was concordance between the quantita-
tive and qualitative components of our study with both
showing that caregivers preferred 14–15 years as the
average age to tell children they were HIV infected. In a
similar pattern, John-Stewart et al. [32] reported that al-
though 79% of Kenyan caregivers answered yes to the
question “is it important for a parent/caregiver to inform
a child of his/her status?” only 19% had disclosed, and
the preferred age of disclosure was 12 years. The pre-
ferred age for commencement of disclosure by the care-
givers we studied is both high and is discordant with
Nigerian National guidelines, [33] the recommendations
by the African Network for the Care of Children Af-
fected by HIV/AIDS (ANECCA), [34] and WHO [6]
which encourage beginning the process of disclosure for
school aged children. This discordance between the pre-
ferred age of disclosure in our study to national and
international guidelines is disturbing. It could be due to
the caregivers’ perception of when the child is psycho-
logically and emotionally mature and has gained relevant
cognitive skills to deal with the disclosure. It further
highlights the perception that disclosure should be a
‘one-time’ event in adolescence rather than a stepwise
and gradual process [35] and implies that children in
our study setting are likely to learn of their HIV-status
suddenly and at an older age. This could have critical
implications for the continuation of HIV care.
In contrast to other reports, [20, 26] girls were 1.45
times more likely than boys to have been disclosed their
HIV positive status. This quantitative finding was cor-
roborated by the qualitative component of our study
where caregivers shared their views that female children
tend to attain ‘maturity’ earlier than their male counter-
parts and would therefore be better equipped to cope
with the news, thus, explaining the higher likelihood of
disclosure to female children in our study setting. Al-
though biological and psychosocial models of develop-
ment may support the assertion by the caregivers in our
study that girls attain physical and psychological matur-
ity earlier than boys, in the context of a complex condi-
tion like HIV, ensuring that caregivers are supported to
make disclosure to their boys and girls alike is critical to
effective treatment uptake.
Although not an independent predictor of disclosure,
having secondary or tertiary education in our study was
associated with a higher likelihood of disclosure to HIV
positive children. Other reports have shown conflicting re-
ports on the influence of caregivers’ educational status on
disclosure to HIV infected children with some suggesting
that attainment of higher levels of education was nega-
tively associated with disclosure to children [36, 37]. This
quantitative finding was further explained by the observa-
tion in the qualitative component of the study that local
traditions, more prevalent among non-educated caregivers
discourage communication on sexuality and HIV infection
between parents and their children. There is therefore a
need to promote and encourage open discussions across
families in the Nigerian context more broadly irrespective
of their educational background, and specifically among
families affected by HIV.
In our study, caregivers who believed that disclosure
was beneficial and should be made to their children liv-
ing with HIV were ten times more likely to disclose the
HIV status to the child. Similar findings have been re-
ported by other studies that have found higher disclos-
ure rates among children of caregivers that understood
the potential health benefit of disclosure [23, 31, 38].
This, therefore, underscores the need for a systematic
approach to providing training, guidance, and support
for caregivers on disclosure to HIV positive children es-
pecially in resource constrained settings with the hope
of encouraging them to believe in disclosure, thus, in-
creasing disclosures to children across context.
Furthermore, our study found that HIV negative care-
givers were twice more likely to disclose HIV status to
their infected children or wards compared to caregivers
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who were HIV positive. This quantitative finding may be
explained by evidence from the qualitative component of
our study which indicated that deep seated feeling of
shame, guilt, self-blame, and self-recrimination among
HIV-positive caregivers strongly influenced disclosure
practices due to their perceived role in unknowingly trans-
mitting HIV to their children during pregnancy, childbirth
and after childbirth. HIV negative caregivers might be less
likely to face these feelings when confronted with making
disclosures, with a correspondingly higher likelihood of
making disclosure to their HIV infected children or wards.
Similar to our findings, Kiwanuka et al. reported that
Ugandan HIV positive caregivers reported fears of being
considered to have been promiscuous or irresponsible by
their children following the disclosure of HIV status to
their infected children [39]. These findings suggest that
the psychological burden of being responsible for the
child’s illness partly impedes the disclosure process by
caregivers. Consequent upon this quantitative finding
whose understanding was enhanced by the qualitative
data, health care workers providing care to HIV positive
children and their caregivers must therefore understand
these undertones to enable them to provide supportive
and empathetic care.
The qualitative data in our study showed that stigma
and discrimination were major caregivers’ concerns pre-
venting disclosure to HIV positive children. Some par-
ents felt their children might harm them or commit
suicide when they became aware of their HIV status.
The high level of stigma and discrimination against
people living with HIV (PLHIV) in many communities
across Nigeria which links HIV infection with promiscu-
ity may perpetuate parental fears of being despised by
their wards following disclosure [40, 41].. Fear of stigma
also fuels the desire of parents to maintain the HIV sta-
tus of family member’s secret - a factor that militates
against early disclosure to children for fear of inadvert-
ent disclosure. Activities aimed at reducing stigma and
discrimination within communities should be strength-
ened in order to reduce this trend.
Disclosure was mostly described as mutually beneficial
for caregivers and children studied. In consonance with
many other reports, [19–21, 42, 43] this study showed
that major benefits accrued from telling children the
truth about their HIV status which included relief for
caregivers and children, improved commitment to in-
volvement in medication and the opportunity to develop
peer support. These benefits further highlight the im-
portance of disclosure thus, strategies aimed at encour-
aging caregivers to make disclosures and supporting
them through the disclosure process should be scaled up
by health systems with similarities to our study context.
Our study has some limitations. Firstly, the fact that we
relied on caregivers’ reported information to determine if
disclosure has been made could have increased the likeli-
hood of reporting bias. This may have decreased or in-
creased our reported prevalence of disclosure. However,
the quantitative questionnaire was researcher adminis-
tered and the fact that an operational definition [6] was
used to define disclosure could have minimized the possi-
bility of this bias. Secondly, we interviewed majorly
women, and HIV positive caregivers which could have in-
fluenced the perspectives and experience shared in the
qualitative narrative data. However, our purposive sample
represent our study setting and therefore, appropriately
reflect the experience from our setting. One should be
cautious when extrapolating our qualitative findings to
other settings with different context.
Conclusion
This sequential, explanatory, mixed-methods study pro-
vides rich and granular research evidence that enhances
the understanding of the barriers, predictors, experience
and the dilemmas caregivers face in disclosing HIV sta-
tus to infected children in a resource limited setting.
HIV status disclosure to infected children was found to
be low in our study setting. Disclosure was affected by
caregivers’ guilt and self-blame, HIV stigma, cultural
sensitivity around HIV infection, the child’s age/gender,
caregivers’ belief on the importance of disclosure, and
caregiver’s HIV status. Despite the pervasive barriers,
disclosure was mostly described by caregivers as mutu-
ally beneficial for caregivers, children, and the con-
tinuum of HIV care. There is, therefore, a critical need
to develop context-specific interventions to support
caregivers who face multiple barriers in disclosing HIV
status to infected children in our study setting. Such in-
terventions could be delivered through the routine HIV
treatment and care system by health workers who are
trained and supported by locally-relevant guidelines
based on local evidence. Through this process, caregivers
would be empowered with practical skills needed to rec-
ognise windows of opportunities to initiate disclosure
early and manage the process in a manner appropriate
to their children’s physical and emotional development.
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